Clinical Trial Update: Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating megestrol acetate for weight loss in dementia patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Rottapharm Spain | Conditions: Dementia | Phase 2, Phase 3 | Status: TERMINATED